MASHINIi

Inventiva S.A..

IVA.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products

Inventiva S.A. is a biopharmaceutical company focused on the discovery and development of innovative therapies for the treatment of diseases with significant unmet medical needs. The company's research and development efforts are primarily directed towards developing oral small molecule therapies ta...Show More

Ethical Profile

Mixed.

Inventiva S.A.'s ethical profile is mixed. The company likely engages in animal testing for drug development, a practice facing increasing scrutiny. However, reports suggest a move towards 3D cell culture solutions as alternatives, aligning with the FDA's evolving stance on phasing out animal testing for certain drug classes. Inventiva's core mission is to develop therapies for unmet medical needs, such as MASH, aiming for "Better Health for All." Yet, its ultimate contribution depends on drug accessibility and pricing. While anti-corruption and whistleblowing policies are in place, comprehensive data on worker respect, environmental impact, and fair sourcing is largely unavailable.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business-20
-100100
Kind to Animals-50
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech-30
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

0

No evidence available to assess Inventiva S.A. on Better Health for All.

Fair Money & Economic Opportunity

0

No evidence available to assess Inventiva S.A. on Fair Money & Economic Opportunity.

Fair Pay & Worker Respect

0

No explicit, quantitative data was found in the provided articles for any of the KPIs related to Fair Pay & Worker Respect. While some articles mention the absence of regulatory actions or violations within specific reports, this is not considered concrete evidence of zero incidents according to the scoring rules, which require explicit data points rather than the absence of mention.

1
The CEO compensation is provided, but median employee compensation is not, preventing the calculation of the CEO-to-median pay ratio.
2

Fair Trade & Ethical Sourcing

0

The provided articles, including financial reports and codes of conduct, do not contain specific, concrete data points for any of the 'Fair Trade & Ethical Sourcing' KPIs. The documents explicitly state that information regarding fair trade certifications, audit frequency, forced/child labor incidents, supply chain traceability, remediation speed, ethical clause coverage in supplier contracts, high-risk materials spend, or supplier diversity spend is not available.

1
While the company relies on third-party manufacturers and is subject to various regulatory inspections for product manufacturing compliance (cGMPs), there is no evidence of specific actions or metrics related to ethical sourcing practices within its supply chain, nor any mention of ethical clauses in supplier contracts.
2

Honest & Fair Business

-20

Inventiva S.A. has a formal whistleblowing policy, established on May 16, 2019, which includes a secure hotline and web form.

1
This policy covers Inventiva and its subsidiaries, outlines confidentiality provisions, details procedures for handling complaints and investigations, and includes protection against retaliation for good-faith reporting.
2
The company also has an anti-corruption policy, updated in 2019, which prohibits bribery and facilitating payments and references compliance with laws such as the FCPA, U.S. Travel Act, UK Bribery Act, and French legislation.
3
However, there is no information on the frequency or effectiveness of training for this policy, nor any data on its enforcement or outcomes.

Kind to Animals

-50

The company conducts preclinical animal testing for its drug candidates, as required by certain laws and regulations.

1
Its public policy articulates a reduction intent, stating that Hyloris (a company mentioned in one article, though the primary company is Inventiva S.A.) will implement alternatives to animal testing where possible.
2
Inventiva S.A.'s technology platform includes in-vitro assays, systems to investigate explant tissue, and advanced electrophysiological methods for assessing neuronal activity. The 'Inner Ear' technology platform is located in a research center with AAALAC accreditation.
3
The company also continues in vitro studies on animals to improve knowledge of drug effects and mechanisms of action.
4

No War, No Weapons

0

No evidence available to assess Inventiva S.A. on No War, No Weapons.

Planet-Friendly Business

0

The provided articles, which primarily focus on Inventiva S.A.'s financial results and regulatory filings, explicitly state that no information is available regarding environmental, social, and governance (ESG) metrics relevant to a planet-friendly business.

1
Consequently, no specific, concrete data points were found to score any of the KPIs against the rubric.

Respect for Cultures & Communities

0

No evidence available to assess Inventiva S.A. on Respect for Cultures & Communities.

Safe & Smart Tech

-30

Inventiva S.A.'s cookie policy indicates an 18-year retention period for an analytic cookie named 'CONSENT'.

1
The company states a commitment to processing personal data in accordance with the GDPR and applicable data protection laws.
2

Zero Waste & Sustainable Products

0

The provided articles primarily detail Inventiva S.A.'s financial performance, clinical trial progress, regulatory designations, and financing activities. They do not contain any specific, concrete data points related to waste management, product sustainability, or circular economy practices.

1
Consequently, no KPIs under the 'Zero Waste & Sustainable Products' value can be scored based on the evidence provided.

Own Inventiva S.A.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.